Optic neuritis occurs due to inflammation of the optic nerve, which is also termed as papillitis (when the head of the optic nerve is involved) and retrobulbar neuritis (when the posterior of the nerve is involved). Optic neuritis is more common relative to the incidence of multiple sclerosis. The minimum point prevalence of visual failure within this population was 3.22 per 100,000.
The minimum point prevalence of visual failure within this population was 3.22 per 100,000. Treatment usually includes steroid medications such as Orason, Deltason, Prednison, Methylprednisolone or others which can speed up the persons vision recovery time.
The primary aim is to develop a framework for evaluating interventions in ON and in order to assess their ability to restore normal tissue, restore optimal neurological function, re-establish normal physiology. People with optic neuritis have a good recovery of their vision and may not have any long term problems with their sight.